126 related articles for article (PubMed ID: 16756973)
1. Tubular transporters and clearance of adefovir.
Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C
Eur J Pharmacol; 2006 Jul; 540(1-3):168-74. PubMed ID: 16756973
[TBL] [Abstract][Full Text] [Related]
2. [Tubular transporters OAT1 and MRP2 and clearance of adefovir].
Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C
Nephrol Ther; 2005 Nov; 1(5):296-300. PubMed ID: 16895698
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
4. Uricosuric Agents Affect Plasma and Kidney Concentration of Adefovir via Inhibition of Oat1 and Mrp2 in Rats.
Motoki K; Taniguchi T; Ashizawa N; Sakai M; Chikamatsu N; Yamano K; Iwanaga T
Biol Pharm Bull; 2023; 46(2):170-176. PubMed ID: 36724945
[TBL] [Abstract][Full Text] [Related]
5. Adefovir accumulation and nephrotoxicity in renal interstitium: Role of organic anion transporters of kidney.
Zhou Y; Yang Y; Wang P; Wei M; Ma Y; Wu X
Life Sci; 2019 May; 224():41-50. PubMed ID: 30902543
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites.
Mallants R; Van Oosterwyck K; Van Vaeck L; Mols R; De Clercq E; Augustijns P
Xenobiotica; 2005; 35(10-11):1055-66. PubMed ID: 16393861
[TBL] [Abstract][Full Text] [Related]
7. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.
Jia W; Du F; Liu X; Jiang R; Xu F; Yang J; Li L; Wang F; Olaleye OE; Dong J; Li C
Drug Metab Dispos; 2015 May; 43(5):669-78. PubMed ID: 25710938
[TBL] [Abstract][Full Text] [Related]
8. Low-dose probenecid selectively inhibits urinary excretion of phenolsulfonphthalein in rats without affecting biliary excretion.
Shin YJ; Lee JH; Oh JH; Lee YJ
J Appl Toxicol; 2013 Jun; 33(6):511-5. PubMed ID: 22161506
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
Cundy KC
Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
[TBL] [Abstract][Full Text] [Related]
10. Developmental expression of renal organic anion transporters in rat kidney and its effect on renal secretion of phenolsulfonphthalein.
Nomura M; Motohashi H; Sekine H; Katsura T; Inui K
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1640-9. PubMed ID: 22419695
[TBL] [Abstract][Full Text] [Related]
11. Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration.
Kearney BP; Ramanathan S; Cheng AK; Ebrahimi R; Shah J
J Clin Pharmacol; 2005 Aug; 45(8):935-40. PubMed ID: 16027404
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule.
Miller DS
J Pharmacol Exp Ther; 2001 Nov; 299(2):567-74. PubMed ID: 11602668
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
[TBL] [Abstract][Full Text] [Related]
14. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.
Imaoka T; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
Mol Pharmacol; 2007 Feb; 71(2):619-27. PubMed ID: 17110501
[TBL] [Abstract][Full Text] [Related]
15. Understanding adefovir pharmacokinetics as a component of a transporter phenotyping cocktail.
Dong Q; Chen C; Taubert M; Bilal M; Kinzig M; Sörgel F; Scherf-Clavel O; Fuhr U; Dokos C
Eur J Clin Pharmacol; 2024 Jul; 80(7):1069-1078. PubMed ID: 38546841
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1.
Mulato AS; Ho ES; Cihlar T
J Pharmacol Exp Ther; 2000 Oct; 295(1):10-5. PubMed ID: 10991954
[TBL] [Abstract][Full Text] [Related]
17. Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.
Laho T; Clarke JD; Dzierlenga AL; Li H; Klein DM; Goedken M; Micuda S; Cherrington NJ
Biochem Pharmacol; 2016 Sep; 115():144-51. PubMed ID: 27381944
[TBL] [Abstract][Full Text] [Related]
18. Apigenin, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1).
Wu T; Li H; Chen J; Cao Y; Fu W; Zhou P; Pang J
Pharmacol Rep; 2017 Dec; 69(6):1254-1262. PubMed ID: 29128807
[TBL] [Abstract][Full Text] [Related]
19. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
20. Impact of the induced organic anion transporter 1 (Oat1) renal expression by furosemide on the pharmacokinetics of organic anions.
Severin MJ; Hazelhoff MH; Bulacio RP; Mamprin ME; Brandoni A; Torres AM
Nephrology (Carlton); 2017 Aug; 22(8):642-648. PubMed ID: 27282888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
